[SCHEDULE 13G] Jaguar Health, Inc. SEC Filing

Rhea-AI Filing Summary

Lincoln Alternative Strategies LLC disclosed ownership of 600,000 shares of Jaguar Health, Inc., representing 18.92% of the outstanding common stock based on 3,171,566 shares as of August 28, 2025. The filing shows Lincoln holds sole voting and sole dispositive power over all 600,000 shares. The Schedule 13G lists the issuer's and filer’s addresses and identifies the filer as a Delaware entity. The filer also certifies the shares were not acquired to change or influence control of the issuer.

Positive

• Material disclosure of stake: 600,000 shares disclosed representing 18.92% of outstanding common stock
• Sole voting and dispositive power: filer reports exclusive control over voting and disposition of the disclosed shares
• Certification of non-control intent: filer states shares were not acquired to change or influence control

Negative

• None.

Insights

Financial Analyst

TL;DR: A nearly 19% stake is material and may influence market perception of Jaguar Health's shareholder base.

Lincoln Alternative Strategies LLC reports beneficial ownership of 600,000 shares (18.92%) with sole voting and dispositive power, a disclosure that is material for market transparency and shareholder-register monitoring. The stake size exceeds typical 5% disclosure thresholds and should be reflected in cap table analyses. The Schedule 13G classification (rather than a Schedule 13D) and the accompanying certification indicate the filer represents the position is not intended to change or influence control, which is relevant when assessing potential activist intent.

Corporate Governance Expert

TL;DR: Significant block ownership reported with assertion of non-control intent; governance teams should note voting concentration.

The filing documents sole voting and dispositive power for 600,000 shares (18.92%) held by a single reporting entity. From a governance perspective, that concentration merits monitoring by the board and investor relations for potential engagement, although the filer explicitly certified the position was not acquired to influence control. The Schedule 13G format aligns with passive or non-control representations, but the size of the holding is large enough to warrant routine outreach and review of any subsequent amendments or Schedule 13D filings.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Jaguar Health, Inc.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

47010C805

(CUSIP Number)

08/28/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 47010C805

1

Names of Reporting Persons

Lincoln Alternative Strategies LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 600,000.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 600,000.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

600,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

18.92 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Beneficial ownership percentage based on 3,171,566 shares of the Issuer's common stock issued and outstanding as of August 28, 2025.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Jaguar Health, Inc.
(b)	Address of issuer's principal executive offices: 200 Pine Street, Suite 400, San Francisco, CA, 94104
Item 2.
(a)	Name of person filing: Lincoln Alternative Strategies LLC
(b)	Address or principal business office or, if none, residence: 404 Washington Ave., Suite 650, Miami Beach, FL 33139
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock, par value $0.0001 per share
(e)	CUSIP No.: 47010C805
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 600,000
(b)	Percent of class: 18.92%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 600,000
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 600,000
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Lincoln Alternative Strategies LLC

Signature:	/s/ Stephen Temes
Name/Title:	Stephen Temes/Managing Member
Date:	08/29/2025

FAQ

How many Jaguar Health (JAGX) shares does Lincoln Alternative Strategies LLC report owning?

The filing reports 600,000 shares beneficially owned by Lincoln Alternative Strategies LLC.

What percentage of JAGX does the 600,000-share position represent?

The filing states the position represents 18.92% of Jaguar Health's common stock based on 3,171,566 shares outstanding as of August 28, 2025.

Does Lincoln report voting or dispositive power over the shares?

Yes; the filer reports sole voting power and sole dispositive power for all 600,000 shares.

Was the stake reported as intended to influence control of Jaguar Health?

No; the Schedule 13G includes a certification that the securities were not acquired and are not held to change or influence control of the issuer.

Who signed the Schedule 13G on behalf of Lincoln Alternative Strategies LLC?

The filing is signed by Stephen Temes, Managing Member, dated August 29, 2025.